Keros Therapeutics, Inc. — SC 13D/A Filings
5 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Keros Therapeutics, Inc. (KROS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Keros Therapeutics, Inc. has filed 5 SC 13D/A documents with the SEC since 2016. To view all SEC filings by Keros Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS EX
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | AMENDMENT NO. 3 | 0000947871-23-001145 | Dec 13, 2023 | — |
| SC 13D/A | AMENDMENT NO. 2 | 0000947871-22-001141 | Nov 7, 2022 | — |
| SC 13D/A | SC 13D/A | 0001178913-20-003385 | Dec 17, 2020 | — |
| SC 13D/A | SC 13D/A | 0001178913-20-003255 | Nov 25, 2020 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000947871-20-000896 | Nov 20, 2020 | — |